Business
CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5
CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius® System.
About this update from Boston Scientific Corporation
[{"type":"text","content":"COPENHAGEN, Denmark, Dec. 10, 2025 /PRNewswire/ -- CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius® System.","length":403,"tagName":"p"},{"type":"image","alt":"Eric Thepaut, Chairman in CathVision.","displaySize":"","headline":null,"caption":"Eric Thepaut, Chairman in CathVision.","className":"","disableSlideshowImg":false,"size":{"original":{"width":360,"height":340,"url":"https://media.zenfs.com/en/prnewswire.com/d11b3ad36417cde63e506a02ad1c634a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9fhfzMsXNkbFobS58f6ktQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTY2NjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d11b3ad36417cde63e506a02ad1c634a","width":360,"height":340}},"href":"https://mma.prnewswire.com/media/2842487/Eric_Thepaut.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Eric Thepaut Appointed Independent Chairman of the Board","length":56,"tagName":"p"},{"type":"text","content":"Eric Thepaut joins CathVision following his recent retirement from Boston Scientific Corporation (NYSE: BSX), where he served as President, EMEA. He brings extensive leadership experience in finance, global commercial operations, and organizational development, with a long track record of scaling teams and businesses across multiple geographies.","length":347,"tagName":"p"},{"type":"text","content":"He led the integration and growth of many acquisitions as well as launched many new technologies. Most recently, he oversaw the successful launch of the company's first Pulse Field Ablation (PFA) device, advancing treatment options for electrophysiologists and improving outcomes for patients suffering from atrial fibrillation.","length":332,"tagName":"p"},{"type":"text","content":""I am pleased to join a very strong team that is delivering a new generation of EP recording technology," said Eric Thepaut, Independent Chairman of the Board. "CathVision's high-signal-quality ECGenius System, combined with its clinical module suite, Cardialytics™, has tremendous potential to help electrophysiologists improve the diagn...